Application 206419
- Type
- ANDA
- Sponsor
- HETERO LABS LTD III
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | CAPSULE, EXTENDED RELEASE;ORAL | 2MG | No | No |
| 002 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | CAPSULE, EXTENDED RELEASE;ORAL | 4MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206419-001 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | 2MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2017-12-12 | |
| A206419-002 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | 4MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2017-12-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206419-001 | AB |
| A206419-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206419-001 | TOLTERODINE TARTRATE | 2MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2017-12-12 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A206419-002 | TOLTERODINE TARTRATE | 4MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2017-12-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206419-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A206419-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tolterodine Tartrate | TOLTERODINE TARTRATE | Camber Pharmaceuticals, Inc. | e16012ae-5972-470b-8a22-b0626a029e95 | 2017-06-03 | Warnings, Adverse reactions | 206419 ANDA206419 31722-608 31722-607 |